Skip to main content

Want a detailed portfolio tracker?

Celcuity (CELC) P/E (2017 - 2026)

Celcuity (CELC) P/E from Oct 2, 2017 to Jul 21, 2026. The TTM Celcuity (CELC) P/E is -21.20. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Celcuity (CELC)

YearP/EChange
2026-21.20-10.52%
2025-23.69+466.95%
2024-4.18-26.52%
2023-5.69-3.41%
2022-5.89-2.11%
2021-6.02-43.04%
2020-10.56-28.30%
2019-14.73-54.65%
2018-32.48-70.08%
2017-108.55N/A

Comparison Celcuity (CELC) P/E with competitors

Celcuity (CELC) P/E is -21.20.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.35%
FGENFibroGen Inc0.24-101.13%
CHRSCoherus Biosciences Inc0.85-104.00%
FBIOFortress Biotech Inc0.95-104.48%
ORMPOramed Pharmaceuticals Inc1.50-107.09%
AGENAgenus Inc3.01-114.20%
INVAInnoviva Inc3.15-114.88%
VXRTVaxart Inc3.55-116.74%
CRMDCorMedix Inc3.63-117.11%
CVACCureVac N.V.4.45-120.97%
GLPGGalapagos NV4.86-122.92%
SRPTSarepta Therapeutics Inc4.88-123.03%
ABEOAbeona Therapeutics Inc5.39-125.41%
ABUSArbutus Biopharma Corp5.60-126.39%
ZVRAZevra Therapeutics Inc5.89-127.77%
SPROSpero Therapeutics Inc6.23-129.38%
CGENCompugen Ltd6.31-129.78%
RIGLRigel Pharmaceuticals6.87-132.41%
SLXNSilexion Therapeutics Corp7.30-134.41%
OMEROmeros Corporation9.26-143.67%
AUPHAurinia Pharmaceuticals Inc9.58-145.21%
PLXProtalix BioTherapeutics Inc10.89-151.37%
ACADAcadia Pharmaceuticals Inc11.73-155.32%
TBPHTheravance Biopharma Inc12.26-157.84%
ADMAAdma Biologics Inc12.42-158.57%
HRMYHarmony Biosciences Holdings Inc13.82-165.19%
SABSSAB Biotherapeutics Inc14.14-166.68%
NAGENiagen Bioscience Inc14.82-169.89%
INCYIncyte Corp15.82-174.63%
REGNRegeneron Pharmaceuticals Inc15.86-174.79%
PBYIPuma Biotechnology Inc17.32-181.67%
CPRXCatalyst Pharmaceuticals Inc17.44-182.26%
EXELExelixis Inc17.54-182.72%
TGTXTG Therapeutics Inc18.97-189.46%
MDXGMimedx Group Inc20.55-196.94%
XOMAXOMA Royalty Corp22.87-207.90%
ARGXArgen X SE24.30-214.61%
CTMXCytomX Therapeutics Inc24.82-217.08%
XOMAOXOMA Royalty Corp25.34-219.55%
HALOHalozyme Therapeutics Inc25.62-220.86%
XOMAPXOMA Royalty Corp25.67-221.08%
VRTXVertex Pharmaceuticals Inc27.99-232.05%
RPRXRoyalty Pharma plc - Class A28.69-235.31%
SLNOSoleno Therapeutics Inc29.02-236.86%
ASNDAscendis Pharma A/S30.09-241.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-278.82%
APLSApellis Pharmaceuticals Inc39.02-284.06%
BMRNBiomarin Pharmaceutical Inc42.21-299.11%
KRYSKrystal Biotech Inc45.34-313.88%
ONCBeiGene Ltd69.54-428.01%
PHARPharming Group N.V.75.03-453.88%
TECHBio-Techne Corp101.96-580.92%
VCELVericel Corp109.92-618.48%
ALNYAlnylam Pharmaceuticals Inc117.96-656.42%
GMABGenmab140.29-761.73%
TLXTelix Pharmaceuticals Ltd162.15-864.84%
CORTCorcept Therapeutics Inc212.86-1104.01%